Spyre Therapeutics (SYRE) Institutional Ownership $25.43 +0.17 (+0.67%) (As of 09:51 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Spyre Therapeutics (NASDAQ:SYRE)CurrentInstitutional OwnershipPercentage80.39%Number ofInstitutional Buyers(last 12 months)42TotalInstitutional Inflows(last 12 months)$275.17MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$9.90M Get SYRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Spyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SYRE Institutional Buying and Selling by Quarter Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Spyre Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.760,666$23.32M0.0%+2.5%1.479% 11/18/2024 Teachers Retirement System of The State of Kentucky21,154$622K0.0%N/A0.041% 11/16/2024 Geode Capital Management LLC891,048$26.21M0.0%+16.4%1.733% 11/15/2024 Barclays PLC105,467$3.10M0.0%+64.7%0.205% 11/15/2024 Jane Street Group LLC20,641$607K0.0%+78.7%0.040% 11/15/2024 Wellington Management Group LLP1,507,200$44.33M0.0%+89.4%2.931% Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp1,541,555$45.34M0.0%+9.4%2.997% 11/15/2024 Ikarian Capital LLC302,247$8.89M1.2%N/A0.588% 11/15/2024 Janus Henderson Group PLC1,120,531$32.92M0.0%+66.3%2.179% 11/15/2024 HighVista Strategies LLC105,351$3.10M1.1%-7.2%0.205% 11/15/2024 Cinctive Capital Management LP61,256$1.80M0.1%N/A0.119% 11/14/2024 Braidwell LP2,189,836$64.40M1.8%-12.9%4.258% 11/14/2024 Walleye Capital LLC243,372$7.16M0.0%+61.4%0.473% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC26,441$778K0.0%-12.2%0.051% 11/14/2024 MetLife Investment Management LLC20,132$592K0.0%+129.1%0.039% 11/13/2024 FMR LLC7,623,881$224.22M0.0%+1.5%14.824% 11/13/2024 The Manufacturers Life Insurance Company43,460$1.28M0.0%+15.0%0.085% 11/12/2024 Charles Schwab Investment Management Inc.333,275$9.80M0.0%+239.4%0.655% 11/9/2024 Intech Investment Management LLC8,371$246K0.0%N/A0.016% 11/7/2024 Quest Partners LLC5,654$166K0.0%+271.2%0.011% 10/29/2024 Emerald Advisers LLC292,569$8.60M0.3%N/A0.575% 10/29/2024 Emerald Mutual Fund Advisers Trust253,550$7.46M0.4%N/A0.498% 10/23/2024 Assenagon Asset Management S.A.1,142,768$33.61M0.1%N/A2.837% 10/3/2024 SG Americas Securities LLC12,589$370K0.0%+127.0%0.031% 8/16/2024 Perceptive Advisors LLC3,031,018$71.26M1.7%+18.6%7.524% 8/16/2024 Driehaus Capital Management LLC687,080$16.15M0.2%N/A1.706% 8/15/2024 The Manufacturers Life Insurance Company37,782$888K0.0%N/A0.094% 8/15/2024 Darwin Global Management Ltd.452,040$10.27M1.2%N/A1.122% 8/15/2024 Armistice Capital LLC136,000$3.20M0.0%N/A0.338% 8/15/2024 Affinity Asset Advisors LLC513,420$12.07M1.4%N/A1.275% 8/14/2024 Great Point Partners LLC134,612$3.17M0.6%N/A0.334% 8/14/2024 Logos Global Management LP575,000$13.52M1.1%N/A1.427% 8/14/2024 Farallon Capital Management LLC666,000$15.66M0.1%N/A1.653% 8/14/2024 Integral Health Asset Management LLC100,000$2.35M0.2%N/A0.248% 8/14/2024 Avoro Capital Advisors LLC1,839,138$43.24M0.6%N/A4.566% 8/14/2024 HighVista Strategies LLC113,550$2.67M1.0%N/A0.282% 8/14/2024 Profund Advisors LLC12,606$296K0.0%N/A0.031% 8/13/2024 Ensign Peak Advisors Inc82,475$1.94M0.0%N/A0.205% 8/12/2024 Amalgamated Bank1,198$28K0.0%N/A0.003% 8/9/2024 Carlyle Group Inc.9,620$227K0.0%N/A0.024% How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now8/8/2024 First Turn Management LLC464,435$10.92M1.8%N/A1.153% 8/6/2024 Quest Partners LLC1,523$36K0.0%N/A0.004% 8/6/2024 Candriam S.C.A.105,000$2.47M0.0%N/A0.261% 8/3/2024 TD Asset Management Inc35,168$827K0.0%N/A0.087% 8/1/2024 Rhumbline Advisers51,896$1.22M0.0%N/A0.129% 7/26/2024 Bank of New York Mellon Corp117,686$2.77M0.0%N/A0.292% 7/26/2024 EFG Asset Management North America Corp.36,781$869K0.2%N/A0.091% 7/12/2024 SG Americas Securities LLC5,545$130K0.0%N/A0.014% (Data available from 1/1/2016 forward) SYRE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SYRE shares? During the previous two years, 44 institutional investors and hedge funds held shares of Spyre Therapeutics. The most heavily invested institutionals were FMR LLC ($224.22M), Perceptive Advisors LLC ($71.26M), Braidwell LP ($64.40M), State Street Corp ($45.34M), Wellington Management Group LLP ($44.33M), Avoro Capital Advisors LLC ($43.24M), and Assenagon Asset Management S.A. ($33.61M).Learn more on SYRE's institutional investors. What percentage of Spyre Therapeutics stock is owned by institutional investors? 80.39% of Spyre Therapeutics stock is owned by institutional investors. Learn more on SYRE's institutional investor holdings. Which institutional investors have been buying Spyre Therapeutics stock? Of the 42 institutional investors that purchased Spyre Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($1.84M), Assenagon Asset Management S.A. ($1.14M), Wellington Management Group LLP ($711.25K), Driehaus Capital Management LLC ($687.08K), Farallon Capital Management LLC ($666K), Logos Global Management LP ($575K), and Affinity Asset Advisors LLC ($513.42K). How much institutional buying is happening at Spyre Therapeutics? Institutional investors have bought a total of 10,690,854 shares in the last 24 months. This purchase volume represents approximately $275.17M in transactions. Which Spyre Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Spyre Therapeutics stock in the last 24 months: Braidwell LP ($324.70K), HighVista Strategies LLC ($8.20K), and UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($3.68K). How much institutional selling is happening at Spyre Therapeutics? Institutional investors have sold a total of 336,581 shares in the last 24 months. This volume of shares sold represents approximately $9.90M in transactions. Related Companies KRYS Institutional Ownership ACLX Institutional Ownership ADMA Institutional Ownership RARE Institutional Ownership BHVN Institutional Ownership APLS Institutional Ownership IMVT Institutional Ownership SRRK Institutional Ownership RNA Institutional Ownership OGN Institutional Ownership This page (NASDAQ:SYRE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYRE Stock Alerts